Steve Glover
Listed on 9 Form D filings across 5+ issuers
· Director
Associated issuers
- BioGene Therapeutics Inc. CIK 2140719 · TX
- Pelion Ventures VIII - Entrepreneurs Fund, L.P. CIK 1975593 · UT
- Pelion Ventures VIII Financial Institutions Fund, L.P. CIK 1971072 · UT
- Pelion Ventures VIII, L.P. CIK 1954493 · UT
- Pelion Ventures VIII-C, L.P. CIK 2008543 · UT
Filings (9)
-
BioGene Therapeutics Inc.D · Aug 7, 2026 · TX · Biotechnology$3MView filing →
-
BioGene Therapeutics Inc.D · Aug 6, 2026 · TX · Biotechnology$250KView filing →
-
BioGene Therapeutics Inc.D · Aug 6, 2026 · TX · Biotechnology$250KView filing →
-
BioGene Therapeutics Inc.D · Aug 6, 2026 · TX · Biotechnology$3MView filing →
-
BioGene Therapeutics Inc.D · Jul 23, 2026 · TX · Biotechnology$4.5MView filing →
-
Pelion Ventures VIII - Entrepreneurs Fund, L.P.D · Jan 28, 2025 · UT · Pooled Investment Fund$23.9MView filing →
-
Pelion Ventures VIII Financial Institutions Fund, L.P.D · Jan 28, 2025 · UT · Pooled Investment Fund$91.2MView filing →
-
Pelion Ventures VIII, L.P.D · Jan 28, 2025 · UT · Pooled Investment Fund$247MView filing →
-
Pelion Ventures VIII-C, L.P.D · Jan 28, 2025 · UT · Pooled Investment Fund$12.9MView filing →